Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

One in three horse owners worming incorrectly
Horse
Small red worm is the most common worm to be found in the UK.

Horses at serious risk from small red worm

One in three horse owners are worming incorrectly, putting their horses at serious risk from encysted small red worm damage, according to figures released from the latest National Equine Health Survey (NEHS).

All horses should be wormed for encysted small red worm during the months of November and December, even if they have a negative faecal worm egg count.

However, this years' National Equine Health Survey revealed that 29 per cent of horse owners who thought they had treated for this fatal parasite had used a product which was not actually indicated to treat them.

Small red worm is the most common worm to be found in the UK and it can be fatal in the encysted stage. Often owners don't know their horse has them because they don't show up in feacal worm egg counts or cause any obvious symptoms.

Only two active ingredients are licensed to treat the parasite: a five-day course of fenbendazole or a single dose of moxidectin. However, resistance to fenbendazole is now widespread in the UK, so experts recommend carrying out a resistance test beforehand
.

The survey revealed that 64 per cent of horse owners who specified how they treated for the parasite had correctly used moxidectin either on its own or in combination with praziquantel (compared with 71 per cent in 2014).

Seven per cent had used fenbendazole. However, of the remainder, 22.5 per cent had used ivermectin, and just over six per cent had used products licensed for tapeworm treatment.

Commenting on the figures, equine veterinary manager Wendy Talbot said: “Encysted small redworm are potentially the most harmful parasites to affect horses in the UK yet the survey results show consistent confusion over the correct product to use to minimise risk.

"It is imperative for owners to discuss their worm control plan with their vet or SQP and use the right product at the right time to safeguard their horses’ health.”

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.